logo
Accelerated biological aging may increase risk of dementia, stroke

Accelerated biological aging may increase risk of dementia, stroke

UPIa day ago

A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says. Photo by Adobe Stock/HealthDay News
A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says.
Shorter telomere length in a person's white blood cells is associated with the two brain diseases, researchers reported Wednesday in the journal Neurology.
However, the link was not found in people with healthy lifestyle habits, researchers added.
"Our findings support the potential benefits of working to improve your risk factors such as maintaining a healthy weight, limiting alcohol and getting enough sleep and exercise in reducing the risk of age-related brain disease even in people who are already showing signs of damaging biological aging," senior researcher Dr. Christopher Anderson, an associate professor of neurology at Harvard Medical School, said in a news release.
Telomeres are protective caps at the ends of chromosomes. Often compared to the plastic tips at the ends of shoelaces, telomeres serve a similar function -- preventing chromosomes from unravelling.
Telomeres shorten every time cells divide, making them useful in estimating a person's biological age, researchers said. Biological age reflects wear-and-tear from the stresses the body endures over time, and can differ greatly from the chronological age reflected by a person's birthday.
For this study, researchers analyzed genetic data for more than 356,000 people participating in UK Biobank, a large-scale health study in England, Scotland and Wales.
Researchers divided the participants into three groups based on whether telomeres in their white blood cells (leukocytes) were short, medium or long.
The team then compared telomere length to each person's lifestyle habits, as well as whether they'd developed dementia, stroke or depression.
During an average seven years of follow-up, nearly 26,000 people developed at least one of these three age-related brain diseases.
People with the shortest telomeres had 5.8 cases of the three brain diseases per 1,000 person-years, compared to 3.9 cases per 1,000 for those with the longest telomeres. Person-years reflect both the number of people in a study and the amount of time each person spends in a study.
Overall, people with short telomeres were 11% more likely to develop one of the brain diseases, after accounting for other risk factors, results show.
They specifically had an 8% increased risk of stroke, 19% increased risk of dementia, and 14% increased risk of late-life dementia, the study says.
However, people with short telomeres didn't have an increased risk if they made healthier lifestyle choices, like eating a good diet and exercising regularly, researchers found.
"These results suggest that healthy lifestyle behaviors could delay the aging of our cells and reduce the frequency of these diseases, especially in people who are greater risk," Anderson said.
Researchers noted that the study can't show a direct cause-and-effect link between telomere length and brain health, only an association between the two.
More information
The University of Utah has more about telomeres and biological aging.
Copyright © 2025 HealthDay. All rights reserved.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Who needs a statin? New Intermountain Study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring
Who needs a statin? New Intermountain Study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring

Yahoo

time30 minutes ago

  • Yahoo

Who needs a statin? New Intermountain Study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring

MURRAY, Utah (ABc4 Utah) – A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease to identify those who would benefit from statin medication to lower their cholesterol. Currently, cardiologists determine a patient's need for a statin medication based on traditional risk factors, which includes using the Pooled Cohort Equation (PCE) to determine their risk. The PCE method calculates coronary risk by assessing risk factors of age, sex, total and HDL cholesterol levels, blood pressure, and whether someone has diabetes and is a smoker. However, a new approach to determining risk and selecting a statin is the use of the coronary artery calcium (CAC) score, which is determined by taking a low-radiation dose image of the heart using computed tomography – a CT scan – to look for calcium deposits in plaques in the heart's coronary arteries. Which approach is more effective? The new study aims to find out. 'Our study is now fully enrolled with over 5,600 patients, and in this abstract, we wanted to look at baseline characteristics and differences in statin prescribing recommendations,' said Jeffrey L. Anderson, MD, co-principal investigator of the study and distinguished clinical and research physician at Intermountain Health. 'The question we want to answer is whether we can do a better job in selecting people who need a statin for primary coronary risk reduction by using the coronary artery calcium score, rather than just putting coronary risk factors into an equation,' said Dr. Anderson. 'That is, is it more effective to use direct imaging to assess evidence of plaque burden or a risk probability equation? That's what we're aiming to find out.' The new study was presented on March 29 at the American College of Cardiology's Annual Scientific Sessions meeting in Chicago. The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart disease. Since 2019, Intermountain heart researchers have enrolled 5,615 patients into the study, with patients having an average age of 64.1 years old, and 51.3% of the study subjects being women. 'This CorCal Outcomes study has been a systemwide, eight-year effort to complete enrollment,' said Dr. Anderson. Intermountain patients at risk of coronary disease were invited to enroll in the study, and those agreeing to participate were randomized into two groups: those assessed using the PCE or those evaluated using their coronary artery calcium score. Results of scoring by their assigned risk assessment tool were sent in letters to their personal physicians, including whether a statin was recommended based on a high-risk score. Patients in the two groups in the study were found to have very similar baseline characteristics. However, researchers found that the rate of statin medication recommendations were different. The study is expected to conclude in early 2026, at which time a comparison of outcomes, including deaths, heart attacks, strokes, and revascularizations during up to seven years, and an average of over four years, of follow-up will be made. For the enrollment phase, researcher found a recommendation to start a statin was made much more often based on the PCE. In the PCE group, 50.7% of patients were recommended a statin, with another 21.7% to be considered for one. By contrast, in the CAC group, only 22.3% of patients were recommended a statin. This large difference in statin recommendations appears to be explained by the strong influence of older age in recommending a statin by the PCE and, in contrast, the frequent finding of a zero or low CAC score in many older patients, leading to a no-statin recommendation in them. Knowing which score is most effective is important, said Dr. Anderson, so that physicians can get statin medication to the right people, and not prescribe statins to those who don't need it. This is especially important considering that statins entail costs and can have side effects, including muscle aches and an increased risk of diabetes. 'We know there's a huge difference in prescribing recommendations, and next year we are anxious to see the impact of these differences on outcomes,' said Dr. Anderson. 'These findings can have a huge impact on how we practice preventive medicine in the future and how many and whom we put on a statin or other lipid-lowering drugs.' Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Sponsored by Intermountain Health. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Accelerated biological aging may increase risk of dementia, stroke
Accelerated biological aging may increase risk of dementia, stroke

Yahoo

time20 hours ago

  • Yahoo

Accelerated biological aging may increase risk of dementia, stroke

A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says. Shorter telomere length in a person's white blood cells is associated with the two brain diseases, researchers reported Wednesday in the journal Neurology. However, the link was not found in people with healthy lifestyle habits, researchers added. "Our findings support the potential benefits of working to improve your risk factors such as maintaining a healthy weight, limiting alcohol and getting enough sleep and exercise in reducing the risk of age-related brain disease even in people who are already showing signs of damaging biological aging," senior researcher Dr. Christopher Anderson, an associate professor of neurology at Harvard Medical School, said in a news release. Telomeres are protective caps at the ends of chromosomes. Often compared to the plastic tips at the ends of shoelaces, telomeres serve a similar function -- preventing chromosomes from unravelling. Telomeres shorten every time cells divide, making them useful in estimating a person's biological age, researchers said. Biological age reflects wear-and-tear from the stresses the body endures over time, and can differ greatly from the chronological age reflected by a person's birthday. For this study, researchers analyzed genetic data for more than 356,000 people participating in UK Biobank, a large-scale health study in England, Scotland and Wales. Researchers divided the participants into three groups based on whether telomeres in their white blood cells (leukocytes) were short, medium or long. The team then compared telomere length to each person's lifestyle habits, as well as whether they'd developed dementia, stroke or depression. During an average seven years of follow-up, nearly 26,000 people developed at least one of these three age-related brain diseases. People with the shortest telomeres had 5.8 cases of the three brain diseases per 1,000 person-years, compared to 3.9 cases per 1,000 for those with the longest telomeres. Person-years reflect both the number of people in a study and the amount of time each person spends in a study. Overall, people with short telomeres were 11% more likely to develop one of the brain diseases, after accounting for other risk factors, results show. They specifically had an 8% increased risk of stroke, 19% increased risk of dementia, and 14% increased risk of late-life dementia, the study says. However, people with short telomeres didn't have an increased risk if they made healthier lifestyle choices, like eating a good diet and exercising regularly, researchers found. "These results suggest that healthy lifestyle behaviors could delay the aging of our cells and reduce the frequency of these diseases, especially in people who are greater risk," Anderson said. Researchers noted that the study can't show a direct cause-and-effect link between telomere length and brain health, only an association between the two. More information The University of Utah has more about telomeres and biological aging. Copyright © 2025 HealthDay. All rights reserved.

Accelerated biological aging may increase risk of dementia, stroke
Accelerated biological aging may increase risk of dementia, stroke

UPI

timea day ago

  • UPI

Accelerated biological aging may increase risk of dementia, stroke

A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says. Photo by Adobe Stock/HealthDay News A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says. Shorter telomere length in a person's white blood cells is associated with the two brain diseases, researchers reported Wednesday in the journal Neurology. However, the link was not found in people with healthy lifestyle habits, researchers added. "Our findings support the potential benefits of working to improve your risk factors such as maintaining a healthy weight, limiting alcohol and getting enough sleep and exercise in reducing the risk of age-related brain disease even in people who are already showing signs of damaging biological aging," senior researcher Dr. Christopher Anderson, an associate professor of neurology at Harvard Medical School, said in a news release. Telomeres are protective caps at the ends of chromosomes. Often compared to the plastic tips at the ends of shoelaces, telomeres serve a similar function -- preventing chromosomes from unravelling. Telomeres shorten every time cells divide, making them useful in estimating a person's biological age, researchers said. Biological age reflects wear-and-tear from the stresses the body endures over time, and can differ greatly from the chronological age reflected by a person's birthday. For this study, researchers analyzed genetic data for more than 356,000 people participating in UK Biobank, a large-scale health study in England, Scotland and Wales. Researchers divided the participants into three groups based on whether telomeres in their white blood cells (leukocytes) were short, medium or long. The team then compared telomere length to each person's lifestyle habits, as well as whether they'd developed dementia, stroke or depression. During an average seven years of follow-up, nearly 26,000 people developed at least one of these three age-related brain diseases. People with the shortest telomeres had 5.8 cases of the three brain diseases per 1,000 person-years, compared to 3.9 cases per 1,000 for those with the longest telomeres. Person-years reflect both the number of people in a study and the amount of time each person spends in a study. Overall, people with short telomeres were 11% more likely to develop one of the brain diseases, after accounting for other risk factors, results show. They specifically had an 8% increased risk of stroke, 19% increased risk of dementia, and 14% increased risk of late-life dementia, the study says. However, people with short telomeres didn't have an increased risk if they made healthier lifestyle choices, like eating a good diet and exercising regularly, researchers found. "These results suggest that healthy lifestyle behaviors could delay the aging of our cells and reduce the frequency of these diseases, especially in people who are greater risk," Anderson said. Researchers noted that the study can't show a direct cause-and-effect link between telomere length and brain health, only an association between the two. More information The University of Utah has more about telomeres and biological aging. Copyright © 2025 HealthDay. All rights reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store